Barinthus Biotherapeutics Stock Forecast

Sell candidate since Jun 29, 2026 Loss -6.13%

The Barinthus Biotherapeutics Plc stock price fell by -3.26% on the last day (Thursday, 2nd Jul 2026) from $0.641 to $0.620. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 6.03% from a day low at $0.590 to a day high of $0.626. The price has fallen in 8 of the last 10 days and is down by -11.21% for this period. Volume has increased on the last day by 49 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 86 thousand shares were bought and sold for approximately $53.42 thousand.

Given the current short-term trend, the stock is expected to rise 18.45% during the next 3 months and, with a 90% probability hold a price between $0.734 and $0.89 at the end of this 3-month period.

BRNS Signals & Forecast

There are few to no technical positive signals at the moment. The Barinthus Biotherapeutics Plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.666 and $0.684. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, June 09, 2026, and so far it has fallen -14.35%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Barinthus Biotherapeutics Plc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Barinthus Biotherapeutics Plc stock

Barinthus Biotherapeutics Plc finds support from accumulated volume at $0.601 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0356 between high and low, or 6.03%. For the last week, the stock has had daily average volatility of 4.87%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BRNS) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Barinthus Biotherapeutics Plc to open at $0.612, and during the day (based on 14 day Average True Range), to move between $0.596 and $0.645, which gives a possible trading interval of +/-$0.0489 (+/-8.21%) up or down from last closing price. If Barinthus Biotherapeutics Plc takes out the full calculated possible swing range there will be an estimated 8.21% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.601 (3.08%) than the resistance at $0.670 (8.05%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Barinthus Biotherapeutics Plc stock A Buy?

The Barinthus Biotherapeutics Plc stock holds several negative signals and despite the positive trend, we believe Barinthus Biotherapeutics Plc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -2.506 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $0.612 ( 1.32%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk